ETF Managers Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$286K	Buy	7,080 +1,895	+37%	+$90.5K	0.01%	548
2022 Q4	$241K	Sell	5,185 -931	-15%	-$42.4K	0.01%	461
2022 Q3	$317K	Sell	6,116 -428	-7%	-$25K	0.01%	546
2022 Q2	$307K	Buy	6,544 +317	+5%	+$17.2K	0.01%	598
2022 Q1	$431K	Buy	6,227 +84	+1%	+$5.47K	0.01%	494
2021 Q4	$458K	Sell	6,143 -1,238	-17%	-$97.2K	0.01%	529
2021 Q3	$414K	Buy	7,381 +1,424	+24%	+$70.4K	0.01%	566
2021 Q2	$261K	Sell	5,957 -222	-4%	-$10.9K	﹤0.01%	595
2021 Q1	$297K	Sell	6,179 -3,587	-37%	-$179K	0.01%	589
2020 Q4	$406K	Sell	9,766 -1,478	-13%	-$65K	0.01%	439
2020 Q3	$504K	Buy	11,244 +5,424	+93%	+$263K	0.02%	305
2020 Q2	$285K	Buy	+5,820	New	+$301K	0.01%	440